Report - DYNAMO: A PHASE 2 STUDY OF DUVELISIB IN …€¦ · DYNAMO: A PHASE 2 STUDY OF DUVELISIB IN PATIENTS WITH REFRACTORY INDOLENT NON‐HODGKIN LYMPHOMA Ian Flinn, CB Miller, KM Ardeshna,

Please pass captcha verification before submit form